Outcome measures
BLOOD, SECONDARY, ADVERSE EVENT
Our co-primary aims were feasibility and safety at 6 months. Feasibility was assessed by trial metrics including proportion of eligible people enrolled, adherence to intervention sessions, participant drop-out rates and missing data for the exploratory clinical outcomes. To assess safety, adverse event data were collected via telehealth at each assessment time point, and during intervention sessions (7). An independent Data Safety Monitor adjudicated adverse event data. Blood pressure was measured using the iHealth Track (KN-550BT) monitor, mailed to participants and collected in accordance with recommended guidelines. Other secondary measures collected via telehealth included self-reported PA (IPAQ), diet quality (Australian Recommended Food Score (ARFS) derived from the Australian Eating Survey,